Ptc Therapeutics Stock Price Prediction
| PTCT Stock | USD 43.88 1.23 2.73% |
Oversold Vs Overbought
45
Oversold | Overbought |
EPS Estimate Next Quarter (1.27) | EPS Estimate Current Year (4.29) | EPS Estimate Next Year (3.75) | Wall Street Target Price 46.1429 | EPS Estimate Current Quarter (1.44) |
Using PTC Therapeutics hype-based prediction, you can estimate the value of PTC Therapeutics from the perspective of PTC Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
PTC Therapeutics Hype to Price Pattern
Investor biases related to PTC Therapeutics' public news can be used to forecast risks associated with an investment in PTC. The trend in average sentiment can be used to explain how an investor holding PTC can time the market purely based on public headlines and social activities around PTC Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of PTC Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about PTC Therapeutics.
The fear of missing out, i.e., FOMO, can cause potential investors in PTC Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying PTC because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
PTC Therapeutics after-hype prediction price | USD 43.88 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
PTC |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PTC Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PTC Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of PTC Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in PTC Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of PTC Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
PTC Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting PTC Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on PTC Therapeutics' historical news coverage. PTC Therapeutics' after-hype downside and upside margins for the prediction period are 40.30 and 47.46, respectively. We have considered PTC Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
PTC Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of PTC Therapeutics is based on 3 months time horizon.
PTC Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as PTC Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PTC Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PTC Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.49 | 3.56 | 0.93 | 1.43 | 9 Events / Month | 5 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
43.88 | 43.88 | 0.00 |
|
PTC Therapeutics Hype Timeline
PTC Therapeutics is at this time traded for 43.88. The entity has historical hype elasticity of -0.93, and average elasticity to hype of competition of 1.43. PTC is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 187.37%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.49%. %. The volatility of related hype on PTC Therapeutics is about 121.96%, with the expected price after the next announcement by competition of 45.31. About 98.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.81. PTC Therapeutics recorded a loss per share of 5.94. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out PTC Therapeutics Basic Forecasting Models to cross-verify your projections.PTC Therapeutics Related Hype Analysis
Having access to credible news sources related to PTC Therapeutics' direct competition is more important than ever and may enhance your ability to predict PTC Therapeutics' future price movements. Getting to know how PTC Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how PTC Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KRYS | Krystal Biotech | 3.19 | 11 per month | 0.00 | (0.06) | 4.45 | (3.75) | 12.05 | |
| SRPT | Sarepta Therapeutics | 2.24 | 8 per month | 0.00 | (0.06) | 3.75 | (3.33) | 9.65 | |
| IOVA | Iovance Biotherapeutics | 0.34 | 8 per month | 0.00 | (0.08) | 7.54 | (6.95) | 23.06 | |
| MDGL | Madrigal Pharmaceuticals | 15.47 | 8 per month | 2.12 | 0.08 | 5.17 | (3.96) | 30.27 | |
| RETA | Reata Pharmaceuticals | (0.50) | 3 per month | 3.31 | 0.02 | 5.24 | (3.51) | 28.80 | |
| ICPT | Intercept Pharmaceuticals | 0.66 | 3 per month | 0.00 | (0.18) | 5.23 | (8.32) | 38.17 | |
| BPMC | Blueprint Medicines Corp | 2.06 | 8 per month | 2.57 | (0.02) | 4.90 | (3.62) | 14.28 | |
| VKTX | Viking Therapeutics | 2.76 | 11 per month | 0.00 | (0.05) | 6.24 | (8.05) | 34.61 | |
| HEPA | Hepion Pharmaceuticals | 0.05 | 3 per month | 0.00 | (0.05) | 8.06 | (8.11) | 33.54 |
PTC Therapeutics Additional Predictive Modules
Most predictive techniques to examine PTC price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PTC using various technical indicators. When you analyze PTC charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About PTC Therapeutics Predictive Indicators
The successful prediction of PTC Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as PTC Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of PTC Therapeutics based on analysis of PTC Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to PTC Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to PTC Therapeutics's related companies. | 2021 | 2022 | 2023 (projected) | Graham Number | 1.85 | 29.13 | 45.39 | Receivables Turnover | 4.88 | 4.49 | 5.82 |
Story Coverage note for PTC Therapeutics
The number of cover stories for PTC Therapeutics depends on current market conditions and PTC Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PTC Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PTC Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
PTC Therapeutics Short Properties
PTC Therapeutics' future price predictability will typically decrease when PTC Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of PTC Therapeutics often depends not only on the future outlook of the potential PTC Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PTC Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 74.8 M | |
| Cash And Short Term Investments | 876.7 M |
Additional Tools for PTC Stock Analysis
When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.